Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency

Article

Abstract: We have reported 1-yr results of a double blind, placebo-controlled trial of recombinant human insul

Palabras claves:

Autores:

Allen L., Gargosky S.E., Jaime Guevara-Aguirre, Martinez V., Rosenbloom A.L., Rosenfeld R.G., Vasconez O.

Fuentes:

scopus